{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:31:22Z","timestamp":1777858282770,"version":"3.51.4"},"reference-count":50,"publisher":"SAGE Publications","issue":"2_suppl","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2008,3]]},"abstract":"<jats:p>Sexual dysfunction is a common but significantly underestimated side effect of antipsychotic medication. It is frequently related to the hyperprolactinaemia that can be induced by dopamine-blocking properties of these agents, but may also be related to the anti-serotonergic properties or anticholinergic and antiadrenergic properties of antipsychotics. Knowledge of the receptor pharmacology of an individual antipsychotic will help to determine whether it is more or less likely to cause sexual side effects.<\/jats:p>","DOI":"10.1177\/0269881107088438","type":"journal-article","created":{"date-parts":[[2008,5,13]],"date-time":"2008-05-13T07:38:40Z","timestamp":1210664320000},"page":"63-69","source":"Crossref","is-referenced-by-count":20,"title":["The impact of hyperprolactinaemia on sexual function in patients with psychosis"],"prefix":"10.1177","volume":"22","author":[{"given":"Shubulade M","family":"Smith","sequence":"first","affiliation":[{"name":"Institute of Psychiatry at Kings College London, PO\rBox 23, Decrespigny Park, Camberwell, London, UK, s.smith@iop.kcl.ac.uk"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2008,3,1]]},"reference":[{"key":"atypb1","unstructured":"Aizenberg D., Zemishlany Z., Dorfman-Etrog P., Weizman A. (1995) Sexual dysfunction in male schizophrenic patients . 56: 137-141"},{"key":"atypb2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(97)00190-X"},{"key":"atypb3","doi-asserted-by":"crossref","unstructured":"Berner MM, Hagen M., Kriston L. (2007) Management of sexual dysfunction due to antipsychotic drug therapy. Cochrane Database Syst Rev24;(1)","DOI":"10.1002\/14651858.CD003546.pub2"},{"key":"atypb4","first-page":"413","volume":"124","year":"1974","journal-title":"The effects of phenothiazines on endocrine function: I Patients with inappropriate lactaction and amenorrhoea"},{"key":"atypb5","first-page":"645","volume":"27","year":"1966","journal-title":"Effect of antipsychotic drugs on reproductive functions"},{"key":"atypb6","first-page":"125","volume":"29","year":"2003","journal-title":"Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study"},{"key":"atypb7","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.12.2087"},{"key":"atypb8","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1176\/ajp.156.2.294","volume":"156","year":"1999","journal-title":"Am J Psychiatry"},{"key":"atypb9","doi-asserted-by":"crossref","unstructured":"Buvat J. (2003) Hyperprolactinemia and sexual function in men: a short review. 15: 373-377","DOI":"10.1038\/sj.ijir.3901043"},{"key":"atypb10","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2006.04.005"},{"key":"atypb11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1992.tb01473.x"},{"key":"atypb12","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.4.659"},{"key":"atypb13","first-page":"165","volume":"21","year":"2007","journal-title":"A naturalistic, 9-month follow-up, comparing olanzapine and conventional antipsychotics on sexual function and hormonal profile for males with schizophrenia"},{"key":"atypb14","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.166.5.642"},{"key":"atypb15","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)80086-7"},{"key":"atypb16","doi-asserted-by":"publisher","DOI":"10.1385\/ENDO:20:1-2:75"},{"key":"atypb17","first-page":"1097","volume":"9","year":"1999","journal-title":"Review of the literature"},{"key":"atypb18","first-page":"251","volume":"21","year":"2006","journal-title":"Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study"},{"key":"atypb19","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145704005012"},{"key":"atypb20","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.schbul.a033413"},{"key":"atypb21","first-page":"843","volume":"20","year":"1990","journal-title":"Subjective utility ratings of neuroleptics in treating schizophrenia"},{"key":"atypb22","first-page":"1523","volume":"80","year":"2000","journal-title":"Prolactin: structure, function, and regulation of secretion Physiol Rev"},{"key":"atypb23","doi-asserted-by":"crossref","unstructured":"Ghadirian A., Chouinard G., Annable L. (1982) Sexual Dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients. 170: 463-467","DOI":"10.1097\/00005053-198208000-00004"},{"key":"atypb24","first-page":"406","volume":"55","year":"1994","journal-title":"Psychotropic medications and their effects on sexual function: diagnosis, biology and treatment approaches"},{"issue":"1","key":"atypb25","first-page":"45","volume":"1","year":"2005","journal-title":"Schizophr Res"},{"key":"atypb26","first-page":"361","volume":"68","year":"2007","journal-title":"Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder"},{"key":"atypb27","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0903"},{"key":"atypb28","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0506"},{"key":"atypb29","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2005.12.006"},{"issue":"2","key":"atypb30","first-page":"109","volume":"28","year":"2003","journal-title":"Psychoneuroendocrinol"},{"key":"atypb31","first-page":"315","volume":"32","year":"2006","journal-title":"A randomized open-label comparison of the impact of olanzapine versus risperidone on sexual functioning"},{"key":"atypb32","first-page":"56","volume":"24","year":"2004","journal-title":"A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning"},{"key":"atypb33","first-page":"56","volume":"37","year":"1996","journal-title":"Sexual Disorders in nonacute psychiatric outpatients"},{"key":"atypb34","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.133.1.82"},{"key":"atypb35","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.182.1.50"},{"key":"atypb36","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0b013e328017f6c4"},{"key":"atypb37","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(03)00050-1"},{"key":"atypb38","first-page":"279","volume":"33","year":"1976","journal-title":"The effect of neuroleptics on serum prolactin in schizophrenic patients"},{"issue":"1","key":"atypb39","first-page":"5S","volume":"49","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"atypb40","first-page":"223","volume":"13","year":"1998","journal-title":"Estrogen replacement therapy and cronary artery disease"},{"key":"atypb41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1997.tb10162.x"},{"key":"atypb42","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(03)00009-9"},{"key":"atypb43","first-page":"611","volume":"28","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"atypb44","first-page":"172","volume":"24","year":"2000","journal-title":"What you don't know won't hurt you: information given to patients about the side-effects of antipsychotic drugs"},{"key":"atypb45","first-page":"49","volume":"4","year":"2002","journal-title":"Sexual dysfunction in patients taking conventional antipsychotic medication"},{"key":"atypb46","first-page":"109","volume":"22","year":"2002","journal-title":"The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic- pituitary-gonadal axis"},{"key":"atypb47","first-page":"393","volume":"25","year":"2004","journal-title":"Prolactin levels and erectile function in patients treated with risperidone"},{"key":"atypb48","first-page":"84","volume":"28","year":"1995","journal-title":"Different patterns of sexual dysfunctions associated with psychiatric disorders and psychopharmacological treatment"},{"key":"atypb49","unstructured":"Thorner MO (2002) Hyperprolactinaemia In Comprehensive Clinical Endocrinology eds: Besser, G. and Thorner, M., ch. 6, 76-84, Mosby , London, UK. Elsevier Science Ltd"},{"key":"atypb50","unstructured":"Von Kraft-Ebing R. (1886) Stuttgart: Ferdinand Enke"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0269881107088438","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0269881107088438","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:10:42Z","timestamp":1777507842000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0269881107088438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":50,"journal-issue":{"issue":"2_suppl","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["10.1177\/0269881107088438"],"URL":"https:\/\/doi.org\/10.1177\/0269881107088438","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}